Please login to the form below

Not currently logged in
Email:
Password:

Sanofi's Steve Oldfield to co-chair UK medicines access group

Takes over from UCB’s Matthew Speers in joint government/industry group

Steve Oldfield, Sanofi Sanofi's managing director of UK & Ireland Steve Oldfield is to co-chair a government/industry group on medicines access.

Oldfield, who has served in his position at Sanofi since 2009, will work alongside the Department of Health's Giles Denham to lead the medicines access group (MAG) – a sub-group of the ministerial industry strategy group, which brings together the biopharma industry and government in the UK.

The MAG meets four times a year to discuss high-level medicines access issues, and includes stakeholders from NICE, the National Commissioning Board and patients groups in addition to industry and government members.

Oldfield, who replaces UCB's Matthew Speers in the role, has previous experience in UK medicines access at a national level, helping to develop the National Metrics Report, which evaluated NICE-approved medicines and their usage and uptake within the NHS.

Commenting on his appointment, Oldifeld praised the work of his successor, but said there was still more to be done.

He said: “Looking ahead to the coming year, I want to push the group forward further still and ensure that we make clear at the highest levels of government that new, life changing medicines are all too often not reaching patients in the UK.

“I am particularly interested in ensuring that the findings and recommendations from the National Metrics Report, and subsequent commentaries on it, result in robust action plans to address the barriers to medicines.”

The CEO of the Association of the British Pharmaceutical Industry (ABPI) Stephen Whitehead welcomed the appointment, stating Oldfield will do an “outstanding job at representing our industry”.

8th February 2013

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
90TEN

90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....